Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico.
Carla M Roman-MontesSaul Bojorges-AguilarEver Arturo Corral-HerreraAndrea Rangel-CorderoPaulette Díaz-LomelíAxel Cervantes-SanchezBernardo Alfonso Martínez-GuerraSandra Rajme-LópezKarla María Tamez-TorresRosa Areli Martínez-GamboaMaria Fernanda Gonzalez-LaraAlfredo Ponce de León-GarduñoJosé Sifuentes-OsornioPublished in: Journal of fungi (Basel, Switzerland) (2023)
Background : Invasive Fungal Infections (IFI) are emergent complications of COVID-19. In this study, we aim to describe the prevalence, related factors, and outcomes of IFI in critical COVID-19 patients. Methods : We conducted a nested case-control study of all COVID-19 patients in the intensive care unit (ICU) who developed any IFI and matched age and sex controls for comparison (1:1) to evaluate IFI-related factors. Descriptive and comparative analyses were made, and the risk factors for IFI were compared versus controls. Results : We found an overall IFI prevalence of 9.3% in COVID-19 patients in the ICU, 5.6% in COVID-19-associated pulmonary aspergillosis (CAPA), and 2.5% in invasive candidiasis (IC). IFI patients had higher SOFA scores, increased frequency of vasopressor use, myocardial injury, and more empirical antibiotic use. CAPA was classified as possible in 68% and 32% as probable by ECMM/ISHAM consensus criteria, and 57.5% of mortality was found. Candidemia was more frequent for C. parapsilosis Fluconazole resistant outbreak early in the pandemic, with a mortality of 28%. Factors related to IFI in multivariable analysis were SOFA score > 2 (aOR 5.1, 95% CI 1.5-16.8, p = 0.007) and empiric antibiotics for COVID-19 (aOR 30, 95% CI 10.2-87.6, p = <0.01). Conclusions : We found a 9.3% prevalence of IFIs in critically ill patients with COVID-19 in a single center in Mexico; factors related to IFI were associated with higher SOFA scores and empiric antibiotic use for COVID-19. CAPA is the most frequent type of IFI. We did not find a mortality difference.
Keyphrases
- sars cov
- coronavirus disease
- risk factors
- intensive care unit
- respiratory syndrome coronavirus
- cardiovascular events
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- mechanical ventilation
- cardiovascular disease
- metabolic syndrome
- skeletal muscle
- adipose tissue
- clinical practice
- pulmonary hypertension